Search company, investor...


Founded Year



Corporate Minority | Alive

Total Raised


Last Raised

$1.85M | 4 yrs ago


JUNTEN BIO develops technologies in the field of regenerative medicine, aiming to eliminate the need for immunosuppressive agents when transplanting organs such as livers and kidneys.

Headquarters Location

Urbannet Nihonbashi 2-chome Building 10F 2-chōme-1-3 Nihonbashi, Chuo City

Tokyo, 103-0027,


Missing: JUNTEN BIO's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: JUNTEN BIO's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing JUNTEN BIO

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

JUNTEN BIO is included in 2 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


JUNTEN BIO has filed 4 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date


Related Topics



Immunology, Immune system, Hepatology, Clusters of differentiation, Diseases of liver


Application Date


Grant Date


Related Topics

Immunology, Immune system, Hepatology, Clusters of differentiation, Diseases of liver



JUNTEN BIO Frequently Asked Questions (FAQ)

  • When was JUNTEN BIO founded?

    JUNTEN BIO was founded in 2018.

  • Where is JUNTEN BIO's headquarters?

    JUNTEN BIO's headquarters is located at Urbannet Nihonbashi 2-chome Building 10F, Tokyo.

  • What is JUNTEN BIO's latest funding round?

    JUNTEN BIO's latest funding round is Corporate Minority.

  • How much did JUNTEN BIO raise?

    JUNTEN BIO raised a total of $12.63M.

  • Who are the investors of JUNTEN BIO?

    Investors of JUNTEN BIO include Fujifilm, H.U. Group Holdings, Daiwa Corporate Investment, Sosei CVC and Nippon Venture Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.